TMPD: Difference between revisions
From Bioblast
(added 'h' to the H-statement numbers) |
No edit summary |
||
Line 25: | Line 25: | ||
:::: During the respirometry experiment it is important to add [[Ascorbate]] into the chamber shortly before TMPD to avoid uncontrolled autoxidation. Ascorbate maintains TMPD in a reduced state, and electrons flow from TMPD to cytochrome ''c''. For preparation and titration please visit [[Ascorbate]]. | :::: During the respirometry experiment it is important to add [[Ascorbate]] into the chamber shortly before TMPD to avoid uncontrolled autoxidation. Ascorbate maintains TMPD in a reduced state, and electrons flow from TMPD to cytochrome ''c''. For preparation and titration please visit [[Ascorbate]]. | ||
::::''' Complex IV assay''':Β For theΒ [[Complex_IV#HRR_protocol:_Complex_IV_assay|Complex IV assay]] TMPD is | ::::''' Complex IV assay''':Β For theΒ [[Complex_IV#HRR_protocol:_Complex_IV_assay|Complex IV assay]] TMPD is used at 0.5 mM concentration in the O2k-chamber added from a 200 mM stock. The abbreviation TMPD is shortened further to the symbol Tm used in DatLab events and SUIT protocol diagrams. | ||
:::: 2021-03: The preparation instructions were updated to take the volume of the solute (TMPD) into account (see: [[Volume_of_the_solute| Volume of the solute]]). | :::: 2021-03: The preparation instructions were updated to take the volume of the solute (TMPD) into account (see: [[Volume_of_the_solute| Volume of the solute]]). | ||
::::''' Preparation of 200 mM stock solution''' (1 mL, dissolved in H<sub>2</sub>O) for '''2-mL O2k-chamber''': | ::::''' Preparation of 200 mM stock solution''' (1 mL, dissolved in H<sub>2</sub>O) for the '''2-mL O2k-chamber''': | ||
::::# Weigh 47.4 mg TMPD | ::::# Weigh 47.4 mg TMPD | ||
::::# Dissolve in 970 Β΅L H<sub>2</sub>O Β | ::::# Dissolve in 970 Β΅L H<sub>2</sub>O Β | ||
Line 39: | Line 39: | ||
::::* Titration volume ('''2-mL O2k-chamber'''): 5 Β΅L using a 25 Β΅L Hamilton syringe. | ::::* Titration volume ('''2-mL O2k-chamber'''): 5 Β΅L using a 25 Β΅L Hamilton syringe. | ||
::::* | ::::* Experimental concentration: 0.5 mM. | ||
Line 52: | Line 52: | ||
::::* Titration volume ('''0.5-mL O2k-chamber'''): 1 Β΅L using a 10 Β΅L Hamilton syringe. | ::::* Titration volume ('''0.5-mL O2k-chamber'''): 1 Β΅L using a 10 Β΅L Hamilton syringe. | ||
::::* | ::::* Experimental concentration: 0.5 mM. | ||
Revision as of 11:31, 6 October 2023
Description
N,N,N',N'-Tetramethyl-p-phenylenediamine dihydrochloride, TMPD, is applied as an artificial substrate for reducing cytochrome c in the respirometric assay for cytochrome c oxidase (CIV) activity. It is maintained in a reduced state by ascorbate and undergoes autoxidation as a function of oxygen pressure, TMPD, ascorbate and cytochrome c concentration.
Abbreviation: Tm
Reference: MiPNet06.06, MiPNet09.12
Application in HRR
- Tm: TMPD (N,N,Nβ²,Nβ²-Tetramethyl-p-phenylenediamine dihydrochloride; C10H16N2*2HCl), Sigma-Aldrich: T3134, store at RT, CAS: 637-01-4, M = 237.2 gΒ·mol-1
- Hazard statements: H315, H319; causes skin irritation, causes serious eye irritation
- Tm: TMPD (N,N,Nβ²,Nβ²-Tetramethyl-p-phenylenediamine dihydrochloride; C10H16N2*2HCl), Sigma-Aldrich: T3134, store at RT, CAS: 637-01-4, M = 237.2 gΒ·mol-1
- Caution: Sensitive to light and oxidation (store solution in a dark vials). Take care to minimize light, oxygen and temperature exposure during use!
- During the respirometry experiment it is important to add Ascorbate into the chamber shortly before TMPD to avoid uncontrolled autoxidation. Ascorbate maintains TMPD in a reduced state, and electrons flow from TMPD to cytochrome c. For preparation and titration please visit Ascorbate.
- Complex IV assay: For the Complex IV assay TMPD is used at 0.5 mM concentration in the O2k-chamber added from a 200 mM stock. The abbreviation TMPD is shortened further to the symbol Tm used in DatLab events and SUIT protocol diagrams.
- 2021-03: The preparation instructions were updated to take the volume of the solute (TMPD) into account (see: Volume of the solute).
- Preparation of 200 mM stock solution (1 mL, dissolved in H2O) for the 2-mL O2k-chamber:
- Weigh 47.4 mg TMPD
- Dissolve in 970 Β΅L H2O
- Divide into 0.2 mL portions in dark vials
- Store frozen at -20 Β°C
- Preparation of 200 mM stock solution (1 mL, dissolved in H2O) for the 2-mL O2k-chamber:
- Β» O2k manual titrations MiPNet09.12 O2k-Titrations
- Titration volume (2-mL O2k-chamber): 5 Β΅L using a 25 Β΅L Hamilton syringe.
- Experimental concentration: 0.5 mM.
- Preparation of 250 mM stock solution (dissolved in H2O) for 0.5-mL O2k-chamber:
- Weigh 59.25 mg TMPD
- Dissolve in 962 Β΅L H2O
- Divide into 0.2 mL portions in dark vials
- Store frozen at -20 Β°C
- Β» O2k manual titrations MiPNet09.12 O2k-Titrations
- Titration volume (0.5-mL O2k-chamber): 1 Β΅L using a 10 Β΅L Hamilton syringe.
- Experimental concentration: 0.5 mM.
MitoPedia topics: Substrate and metabolite